Company registration number 13218833 (England and Wales)
PHARMACARE GROUP LTD
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2024
PAGES FOR FILING WITH REGISTRAR
PHARMACARE GROUP LTD
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 3
PHARMACARE GROUP LTD
BALANCE SHEET
AS AT 30 JUNE 2024
30 June 2024
- 1 -
2024
2023
Notes
£
£
£
£
Fixed assets
Tangible assets
2
3,326
2,957
Current assets
Debtors
3
249,997
166,266
Cash at bank and in hand
25,384
15,968
275,381
182,234
Creditors: amounts falling due within one year
4
(121,710)
(173,158)
Net current assets
153,671
9,076
Total assets less current liabilities
156,997
12,033
Provisions for liabilities
(546)
(515)
Net assets
156,451
11,518
Capital and reserves
Called up share capital
5
400
400
Profit and loss reserves
156,051
11,118
Total equity
156,451
11,518

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 30 June 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the board of directors and authorised for issue on 21 March 2025 and are signed on its behalf by:
Mrs A-L Wagstaff
Director
Company registration number 13218833 (England and Wales)
PHARMACARE GROUP LTD
BALANCE SHEET (CONTINUED)
AS AT 30 JUNE 2024
30 June 2024
- 2 -
1
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2024
2023
Number
Number
Total
7
6
2
Tangible fixed assets
Plant and machinery
£
Cost
At 1 July 2023
3,607
Additions
1,746
At 30 June 2024
5,353
Depreciation and impairment
At 1 July 2023
650
Depreciation charged in the year
1,377
At 30 June 2024
2,027
Carrying amount
At 30 June 2024
3,326
At 30 June 2023
2,957
3
Debtors
2024
2023
Amounts falling due within one year:
£
£
Trade debtors
167,785
65,430
Other debtors
82,212
100,836
249,997
166,266
4
Creditors: amounts falling due within one year
2024
2023
£
£
Trade creditors
-
0
69,391
Taxation and social security
106,054
32,854
Other creditors
15,656
70,913
121,710
173,158
PHARMACARE GROUP LTD
BALANCE SHEET (CONTINUED)
AS AT 30 JUNE 2024
30 June 2024
- 3 -
5
Called up share capital
2024
2023
2024
2023
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary 'A' shares of £1 each
133
133
133
133
Ordinary 'B' shares of £1 each
133
133
133
133
Ordinary 'C' shares of £1 each
134
134
134
134
400
400
400
400
2024-06-302023-07-01false21 March 2025CCH SoftwareCCH Accounts Production 2024.100No description of principal activityMr M GlasmacherMrs A M Wagstafffalsefalse132188332023-07-012024-06-30132188332024-06-30132188332023-06-3013218833core:OtherPropertyPlantEquipment2024-06-3013218833core:OtherPropertyPlantEquipment2023-06-3013218833core:CurrentFinancialInstrumentscore:WithinOneYear2024-06-3013218833core:CurrentFinancialInstrumentscore:WithinOneYear2023-06-3013218833core:CurrentFinancialInstruments2024-06-3013218833core:CurrentFinancialInstruments2023-06-3013218833core:ShareCapital2024-06-3013218833core:ShareCapital2023-06-3013218833core:RetainedEarningsAccumulatedLosses2024-06-3013218833core:RetainedEarningsAccumulatedLosses2023-06-3013218833core:ShareCapitalOrdinaryShares2024-06-3013218833core:ShareCapitalOrdinaryShares2023-06-3013218833bus:Director22023-07-012024-06-30132188332022-07-012023-06-3013218833core:OtherPropertyPlantEquipment2023-06-3013218833core:OtherPropertyPlantEquipment2023-07-012024-06-3013218833core:WithinOneYear2024-06-3013218833core:WithinOneYear2023-06-3013218833bus:PrivateLimitedCompanyLtd2023-07-012024-06-3013218833bus:SmallCompaniesRegimeForAccounts2023-07-012024-06-3013218833bus:FRS1022023-07-012024-06-3013218833bus:AuditExemptWithAccountantsReport2023-07-012024-06-3013218833bus:Director12023-07-012024-06-3013218833bus:FullAccounts2023-07-012024-06-30xbrli:purexbrli:sharesiso4217:GBP